Skip to content

Randomized controlled study of fire needle in the treatment of refractory migraine

Randomized controlled study of fire needle in the treatment of refractory migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001483
Enrollment
Unknown
Registered
2025-07-26
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory migraine

Interventions

treatment group:Fire needle combined with needle
control group:filiform needle acupuncture

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 Conform to the diagnostic criteria of western medicine refractory migraine Age 18 to 65 years old 3 In the past 3 months, there was no acupuncture treatment for migraine and preventive medication for migraine. 4 Without language and mental retardation, migraine diary can be successfully completed. 5 Those who signed the informed consent form

Exclusion criteria

Exclusion criteria: 1 Patients with cluster headache, mental headache and other causes of headache 2 Headache caused by systemic diseases, such as cardiovascular diseases, acute infectious diseases, blood diseases, endocrine and metabolic diseases, allergic reactions, poisoning, etc. 3 Headache caused by five sense organs diseases, such as glaucoma, otitis media, sinusitis, pericoronitis of wisdom teeth, etc. 4 Headache caused by intracranial organic lesions, such as intracranial infection, brain tumor, subarachnoid hemorrhage, etc. 5 patients with epilepsy, pregnancy, mental illness or drug abuse

Design outcomes

Primary

MeasureTime frame
Monthly migraine attack days;response rate;

Secondary

MeasureTime frame
Degree of headache attack;Number of Analgesics Used;quality of life;headache attack frequency;headache duration;

Countries

the People's Republic of China

Contacts

Public ContactYizhan Wang

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

wangyizhancn@126.com15311368116

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026